| Market Capitalization (Millions $) |
54,375 |
| Shares
Outstanding (Millions) |
398 |
| Employees |
4,700 |
| Revenues (TTM) (Millions $) |
2,228 |
| Net Income (TTM) (Millions $) |
-3,151 |
| Cash Flow (TTM) (Millions $) |
628 |
| Capital Exp. (TTM) (Millions $) |
171 |
Business Description
Moderna Inc. is a biotechnology company that specializes in the development of messenger RNA (mRNA) therapeutics and vaccines. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
The company is at the forefront of the mRNA technology, which essentially involves using mRNA to instruct cells in the body to produce therapeutic proteins or stimulate an immune response against specific diseases. This approach has gained significant attention and recognition, especially during the COVID-19 pandemic, as Moderna successfully developed one of the first mRNA-based vaccines against the virus.
In addition to COVID-19, Moderna is actively involved in the development of mRNA vaccines and therapies targeting a range of other diseases, including influenza, Zika virus, and various types of cancer. The company's pipeline includes multiple candidates in different stages of development, demonstrating its commitment to advancing mRNA technology for various medical applications.
Moderna has established collaborations with pharmaceutical companies, government organizations, and academic institutions to enhance its research capabilities and expedite the development of its therapies and vaccines. The company has also made significant investments in manufacturing facilities to support large-scale production of its products.
As of 2021, Moderna has emerged as a leading player in the field of mRNA therapeutics and vaccines, with its COVID-19 vaccine receiving emergency use authorizations and playing a crucial role in the global vaccination efforts. The company continues to focus on advancing the potential of mRNA technology to address various diseases, and its innovative approach has positioned it as a key contributor to the future of biotechnology.
Company Address: 325 Binney Street Cambridge, 2142 MA
Company Phone Number: 714-6500 Stock Exchange / Ticker: NASDAQ MRNA
|
1.78% 
307.59 %